The antibody treatment, sasanlimab, in combination with Bacillus Calmette-Guérin (BCG) vaccine met the main goal of the study ...

Abbvie said on Friday it will record a charge of about $3.5 billion related to its experimental schizophrenia drug, ...

Pfizer on Friday said the pivotal Phase 3 study evaluating sasanlimab in combination with standard-of-care Bacillus Calmette-Guerin, or BCG, as induction therapy with or without maintenance in ...

As for GBS itself, this neurological ailment can be severe, attacking nerves and warranting hospitalisation for weeks or ...

Eli Lilly is making a play for the idiopathic pulmonary fibrosis (IPF) market, offering Mediar Therapeutics $99 million in ...

Royalty Pharma said on Friday it would pay about $1.1 billion to acquire RP Management, an organization that manages the healthcare firm's operations, as it seeks to simplify its corporate structure.

A Canadian teen's breasts grew fourfold after receiving the Pfizer COVID-19 vaccine, raising concerns about a rare condition ...

On Tuesday, January 7, the FDA announced it would now be requiring GSK and Pfizer’s RSV vaccines to hold warnings of a risk ...

For most investors, generating consistent income alongside capital appreciation is a common goal. For those seeking a blend ...

Seasoned biotechnology industry leadership spanning three decades across U.S. and global commercial operationsBRISBANE, Calif., Jan. 10, 2025 (GLOBE NEWSWIRE) -- Annexon, Inc. (Nasdaq: ANNX), a ...

With NHS trusts struggling to cope as cases of winter flu soar, a study has warned that respiratory infections cost employers ...

Companies seeking to benefit from campaign promises to cut regulations and taxes are ditching diversity and climate ...